Drug ID: | NPD6291 |
Drug Name: | |
Molecular Formula: | C25H30F2O6S |
Canonical SMILES: | O=C1C=C[C@]2(C(=C1)[C@@H](F)C[C@@H]1C2(F)[C@@H](O)C[C@]2(C1C[C@H]([C@]2(O)C(=O)S[C@@H]1CCOC1=O)C)C)C |
Standard InCHI: | InChI=1S/C25H30F2O6S/c1-12-8-14-15-10-17(26)16-9-13(28)4-6-22(16,2)24(15,27)19(29)11-23(14,3)25(12,32)21(31)34-18-5-7-33-20(18)30/h4,6,9,12,14-15,17-19,29,32H,5,7-8,10-11H2,1-3H3/t12-,14?,15+,17+,18-,19+,22+,23+,24?,25+/m1/s1 |
Standard InCHIKey: | OJRPWVDDBGJONP-RCWMBTMBSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7